SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gharavi, A E
Right arrow Articles by Pierangeli, S S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gharavi, A E
Right arrow Articles by Pierangeli, S S
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies

A E Gharavi

Department of Medicine, Morehouse School of Medicine, Atlanta, GA, USA

M Vega-Ostertag

Antiphospholipid Standardization Laboratory, Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA

R G Espinola

Antiphospholipid Standardization Laboratory, Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA

X Liu

Antiphospholipid Standardization Laboratory, Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA

L Cole

Department of Medicine, Morehouse School of Medicine, Atlanta, GA, USA

N T Cox

Department of Medicine, Morehouse School of Medicine, Atlanta, GA, USA

P Romagnoli

Department of Medicine, Morehouse School of Medicine, Atlanta, GA, USA

K Labat

Antiphospholipid Standardization Laboratory, Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA

S S Pierangeli

Antiphospholipid Standardization Laboratory, Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA, pierans{at}msm.edu

Immunization of mice with ß2 glycoprotein I (ß2 GPI) and also with GDKV, a synthetic peptide representing the phospholipid (PL)-binding site of ß2 GPI, induced pathogenic aPL antibodies that bind and activate endothelial cells, enhanced thrombus formation and caused fetal death in pregnant mice. TIFI is a PL-binding peptide spanning the Thr101-Thr120 of ulb0-hcmva from human cytomegalovirus (CMV), which shares structural similarity with the PL-binding site of ß2 GPI. Immunization with this peptide induced pathogenic aPL and anti-ß2 GPI antibodies in mice. These antibodies activated endothelial cells and enhanced thrombus formation in vivo, but whether these antibodies cause fetal death in mice is not known. The objectiveof this study was to examine the effects of these antibodieson pregnancyoutcomein mice. Two groups of pregnantBALB/c mice were injected with either hybridoma supernatant containing D3/AC10, a CMV-peptide-induced monoclonal aPL, at days four, eight and 12 of the pregnancy, 100 m g per mouse (study group) or with culture media alone (control group). The litter size was significantly smaller in the study group (4.80 + 1.15 versus 7.28 + 0.18, t =- 2.526, P < 0.03). In conclusion, aPL induced by CMV peptides may have pathogenic properties similar to human autoimmune aPL. These findings further support the hypothesis that at least in some patients with APS, pathogenic aPL antibodies may be generated by immunization with CMV products during incidental exposure to the virus via a molecular mimicry mechanism.

Key Words: anticardiolipin antibodies • antiphospholipid antibodies • antiphospholipid syndrome • CMV • molecular mimicry • pregnancy loss

Lupus, Vol. 13, No. 1, 17-23 (2004)
DOI: 10.1191/0961203304lu484oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
N. Agmon-Levin, M. Blank, Z. Paz, and Y. Shoenfeld
Molecular mimicry in systemic lupus erythematosus
Lupus, November 1, 2009; 18(13): 1181 - 1185.
[Abstract] [PDF]


Home page
Int ImmunolHome page
M. Blank, L. Anafi, G. Zandman-Goddard, I. Krause, S. Goldman, E. Shalev, R. Cervera, J. Font, M. Fridkin, H.-J. Thiesen, et al.
The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model
Int. Immunol., July 1, 2007; 19(7): 857 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-X. Chen, Y.-Y. Gu, S.-J. Li, J. Qian, K.-K. Hwang, P. P. Chen, S.-L. Chen, and C.-D. Yang
Some Plasmin-Induced Antibodies Bind to Cardiolipin, Display Lupus Anticoagulant Activity and Induce Fetal Loss in Mice
J. Immunol., April 15, 2007; 178(8): 5351 - 5356.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
Y Shoenfeld and M Blank
Autoantibodies associated with reproductive failure
Lupus, September 1, 2004; 13(9): 643 - 648.
[Abstract] [PDF]



Advertisement